CD117 (c-kit) Expression on CD34+ Cells Participates in the Cytogenetic Response to Imatinib in Patients with Chronic Myeloid Leukemia in the First Chronic Phase

Publisher： Karger

E-ISSN： 1421-9662|132|2|166-171

ISSN： 0001-5792

Source： Acta Haematologica, Vol.132, Iss.2, 2014-02, pp. : 166-171

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Changes in Expression of Apoptosis-Related Genes Are Linked to the Molecular Response to Imatinib Treatment in Chronic-Phase Chronic Myeloid Leukemia Patients

By  

Acta Haematologica, Vol. 117, Iss. 2, 2006-11 ,pp. : 83-90

Karger

Access to resources Recommend Favorite

Atypical Chronic Myeloid Leukaemia with CD117-Positive Blast Cells Treated with Imatinib: A Report of Two Cases

By  

Acta Haematologica, Vol. 116, Iss. 3, 2006-10 ,pp. : 211-212

Karger

Access to resources Recommend Favorite

Imatinib plus Granulocyte Colony-Stimulating Factor in Chronic Myeloid Leukemia Patients Who Have Achieved Partial or Complete Cytogenetic Response while on Imatinib

By  

Case Reports in Oncology, Vol. 4, Iss. 1, 2011-04 ,pp. : 192-197

Karger

Access to resources Recommend Favorite

Pretherapeutic Expression of the hOCT1 Gene Predicts a Complete Molecular Response to Imatinib Mesylate in Chronic-Phase Chronic Myeloid Leukemia

By  

Acta Haematologica, Vol. 127, Iss. 4, 2012-04 ,pp. : 228-234

Karger

Access to resources Recommend Favorite

Homoharringtonine Combined with Cytarabine to Treat Chronic Myelogenous Leukemia in Myeloid Blast Crisis and Its Impact on Bone Marrow CD34+CD7+ Cells

By  

Acta Haematologica, Vol. 132, Iss. 2, 2014-03 ,pp. : 172-176

Karger

Access to resources Recommend Favorite